New Antiviral Nasal Spray Outperforms Current Antibody Treatments for COVID-19 and Its Variants in Mice - SciTechDaily

A single inhaled dose treated or even prevented infection by COVID-19 and its variants. Current antibody treatments block SARS-CoV-2 by binding to one of three binding sites on the spike protein New antiviral binds to all three sites on the spike protein, mak…

A single inhaled dose treated or even prevented infection by COVID-19 and its variants.

• Current antibody treatments block SARS-CoV-2 by binding to one of three binding sites on the spike pro… [+7623 chars]
  full article...